FDA Inspection 1096150 — Vitalant Magee Women's Hospital Site
The FDA completed an inspection of Vitalant Magee Women's Hospital Site on June 10, 2019 in Pittsburgh, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 10, 2019
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Pittsburgh, PA (United States)